Organization Profile

Related Organization(s)

You just read:

Health Canada Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder

News provided by

Otsuka

Feb 22, 2019, 14:35 ET